Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy
Interventions
DEVICE

1064 nm Nd:YAG laser

The laser used will be a 1064 nm Nd:YAG, with a 10ns pulse, 3mm spot size and 4 joules of energy

DRUG

Imiquimod, 5% cream

2 weeks after the laser procedure the imiquimod will be applied 3 times a week for one month

Trial Locations (1)

33136

Mohs, Dermatologic and Laser Surgery, Miami

Sponsors
All Listed Sponsors
collaborator

Graceway Pharmaceuticals, LLC

INDUSTRY

lead

University of Miami

OTHER